WEN CHEN

Allopathic & Osteopathic Physicians|Psychiatry & Neurology|Neurology NEWPORT NEWS, VA NPI 1992123764

General Payments — all program years on this page

$6,657.04

  • Category: General Payments
  • Program years: PY2018–2024
  • Record count: 366
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $588.26 across 22 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $388.2620
Education $200.002

By paying entity

Latest program year (PY2024) · sorted by reported total.

By program year

Program yearAmountRecords
2018 $878.7951
2019 $1,390.1581
2020 $1,079.6465
2021 $792.7354
2022 $1,017.1051
2023 $910.3742
2024 $588.2622

Records — PY2024 (22)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1093893740 Alexion Pharmaceuticals, Inc. $100.00 10/16/2024 Education Undisputed 01/23/2026 View at CMS
1093896024 Alexion Pharmaceuticals, Inc. $100.00 10/16/2024 Education Undisputed 01/23/2026 View at CMS
1103454016 ABBVIE INC. $15.83 04/17/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104805551 Biogen, Inc. $15.75 07/01/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104809983 Biogen, Inc. $15.12 12/02/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104811775 Biogen, Inc. $1.61 07/01/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104819544 Biogen, Inc. $4.95 10/03/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104820008 Biogen, Inc. $28.60 05/20/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104843198 Biogen, Inc. $28.73 08/08/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104846538 Biogen, Inc. $18.17 10/03/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104856764 Biogen, Inc. $16.17 07/29/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104863290 Biogen, Inc. $9.32 02/15/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104875138 Biogen, Inc. $28.45 04/22/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105918682 VERTEX PHARMACEUTICALS INCORPORATED $21.03 10/23/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1131004187 PFIZER INC. $23.11 11/04/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1131782478 PFIZER INC. $13.20 08/21/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1131966689 PFIZER INC. $14.61 09/24/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1133132345 Genentech USA, Inc. $29.08 11/18/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1133421105 Averitas Pharma Inc. $23.68 09/30/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135481187 Lilly USA, LLC $24.42 08/19/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1139182474 Amneal Pharmaceuticals LLC $14.84 10/15/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1143269183 UCB, Inc. $41.59 08/26/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.